Press Releases
KARO BIO AND WYETH EXTEND RESEARCH COLLABORATION
Thursday, August 14, 2008
KARO BIO ANNOUNCES SUCCESSFUL PHASE II STUDY WITH EPROTIROME IN COMBINATION WITH STATIN
Monday, August 04, 2008
Events / Presentations
Financial Reports
INTERIM REPORT JANUARY–JUNE 2008
Tuesday, August 05, 2008
INTERIM REPORT JANUARY–MARCH 2008
Thursday, April 24, 2008
Share price
9/5/2008 6:01 PM
-2.42% 8.05 SEK, Vol: 826042
Search
Business Model
Generate new innovative projects through drug discovery targeting nuclear receptors
Reduce risk by maintaining a focused project portfolio and building a clinical pipeline
Bring selected projects in niche areas to the market or late stage out licensing
License out compounds intended for treatment of broad patient populations
Read more »
Karo Bio Pipeline
Read more »